Cargando…
Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction
Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI we...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480296/ https://www.ncbi.nlm.nih.gov/pubmed/37670005 http://dx.doi.org/10.1038/s41598-023-37093-1 |
_version_ | 1785101763918954496 |
---|---|
author | Yufera-Sanchez, Ana Lopez-Ayala, Pedro Nestelberger, Thomas Wildi, Karin Boeddinghaus, Jasper Koechlin, Luca Rubini Gimenez, Maria Sakiz, Hüseyin Bima, Paolo Miro, Oscar Martín-Sánchez, F. Javier Christ, Michael Keller, Dagmar I. Gualandro, Danielle M. Kawecki, Damian Rentsch, Katharina Buser, Andreas Mueller, Christian |
author_facet | Yufera-Sanchez, Ana Lopez-Ayala, Pedro Nestelberger, Thomas Wildi, Karin Boeddinghaus, Jasper Koechlin, Luca Rubini Gimenez, Maria Sakiz, Hüseyin Bima, Paolo Miro, Oscar Martín-Sánchez, F. Javier Christ, Michael Keller, Dagmar I. Gualandro, Danielle M. Kawecki, Damian Rentsch, Katharina Buser, Andreas Mueller, Christian |
author_sort | Yufera-Sanchez, Ana |
collection | PubMed |
description | Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI were measured in consecutive patients presenting with acute chest discomfort to the emergency department (ED) and enrolled in a large international diagnostic study (NCT00470587). Two independent cardiologists centrally adjudicated the final diagnosis using all clinical data, including serial hs-cTnT measurements, cardiac imaging and clinical follow-up. The primary diagnostic endpoint was index non-ST-segment elevation MI (NSTEMI). Prognostic endpoints were all-cause death, and cardiovascular (CV) death or future AMI, all within 730-days. Among 5639 eligible patients, NSTEMI was the adjudicated final diagnosis in 1051 (18.6%) patients. Diagnostic accuracy quantified using the area under the receiver-operating characteristics curve (AUC) for the combination of glucose with hs-cTnT and glucose with hs-cTnI was very high, but not higher versus that of hs-cTn alone (glucose/hs-cTnT 0.930 [95% CI 0.922–0.937] versus hs-cTnT 0.929 [95% CI 0.922–0.937]; glucose/hs-cTnI 0.944 [95% CI 0.937–0.951] versus hs-cTnI 0.944 [95% CI 0.937–0.951]). In early-presenters, a dual-marker strategy (glucose < 7 mmol/L and hs-cTnT < 5/hs-cTnI < 4 ng/L) provided very high and comparable sensitivity to slightly lower hs-cTn concentrations (cTnT/I < 4/3 ng/L) alone, and possibly even higher efficacy. Glucose was an independent predictor of 730-days endpoints. Our results showed that a dual marker strategy of glucose and hs-cTn did not increase the diagnostic accuracy when used continuously. However, a cutoff approach combining glucose and hs-cTn may provide diagnostic utility for patients presenting ≤ 3 h after onset of symptoms, also providing important prognostic information. |
format | Online Article Text |
id | pubmed-10480296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104802962023-09-07 Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction Yufera-Sanchez, Ana Lopez-Ayala, Pedro Nestelberger, Thomas Wildi, Karin Boeddinghaus, Jasper Koechlin, Luca Rubini Gimenez, Maria Sakiz, Hüseyin Bima, Paolo Miro, Oscar Martín-Sánchez, F. Javier Christ, Michael Keller, Dagmar I. Gualandro, Danielle M. Kawecki, Damian Rentsch, Katharina Buser, Andreas Mueller, Christian Sci Rep Article Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI were measured in consecutive patients presenting with acute chest discomfort to the emergency department (ED) and enrolled in a large international diagnostic study (NCT00470587). Two independent cardiologists centrally adjudicated the final diagnosis using all clinical data, including serial hs-cTnT measurements, cardiac imaging and clinical follow-up. The primary diagnostic endpoint was index non-ST-segment elevation MI (NSTEMI). Prognostic endpoints were all-cause death, and cardiovascular (CV) death or future AMI, all within 730-days. Among 5639 eligible patients, NSTEMI was the adjudicated final diagnosis in 1051 (18.6%) patients. Diagnostic accuracy quantified using the area under the receiver-operating characteristics curve (AUC) for the combination of glucose with hs-cTnT and glucose with hs-cTnI was very high, but not higher versus that of hs-cTn alone (glucose/hs-cTnT 0.930 [95% CI 0.922–0.937] versus hs-cTnT 0.929 [95% CI 0.922–0.937]; glucose/hs-cTnI 0.944 [95% CI 0.937–0.951] versus hs-cTnI 0.944 [95% CI 0.937–0.951]). In early-presenters, a dual-marker strategy (glucose < 7 mmol/L and hs-cTnT < 5/hs-cTnI < 4 ng/L) provided very high and comparable sensitivity to slightly lower hs-cTn concentrations (cTnT/I < 4/3 ng/L) alone, and possibly even higher efficacy. Glucose was an independent predictor of 730-days endpoints. Our results showed that a dual marker strategy of glucose and hs-cTn did not increase the diagnostic accuracy when used continuously. However, a cutoff approach combining glucose and hs-cTn may provide diagnostic utility for patients presenting ≤ 3 h after onset of symptoms, also providing important prognostic information. Nature Publishing Group UK 2023-09-05 /pmc/articles/PMC10480296/ /pubmed/37670005 http://dx.doi.org/10.1038/s41598-023-37093-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yufera-Sanchez, Ana Lopez-Ayala, Pedro Nestelberger, Thomas Wildi, Karin Boeddinghaus, Jasper Koechlin, Luca Rubini Gimenez, Maria Sakiz, Hüseyin Bima, Paolo Miro, Oscar Martín-Sánchez, F. Javier Christ, Michael Keller, Dagmar I. Gualandro, Danielle M. Kawecki, Damian Rentsch, Katharina Buser, Andreas Mueller, Christian Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
title | Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
title_full | Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
title_fullStr | Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
title_full_unstemmed | Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
title_short | Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
title_sort | combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480296/ https://www.ncbi.nlm.nih.gov/pubmed/37670005 http://dx.doi.org/10.1038/s41598-023-37093-1 |
work_keys_str_mv | AT yuferasanchezana combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT lopezayalapedro combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT nestelbergerthomas combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT wildikarin combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT boeddinghausjasper combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT koechlinluca combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT rubinigimenezmaria combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT sakizhuseyin combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT bimapaolo combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT mirooscar combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT martinsanchezfjavier combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT christmichael combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT kellerdagmari combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT gualandrodaniellem combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT kaweckidamian combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT rentschkatharina combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT buserandreas combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT muellerchristian combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction AT combiningglucoseandhighsensitivitycardiactroponinintheearlydiagnosisofacutemyocardialinfarction |